02 8011 4217, 0416 974 651  info at scenar.com.au

Conference Round Table

Do not forget to bring your most difficult and challenging case studies.

These will be discussed and resolved during the Round Table session on 6th of March.

You will be able to consult with the most experienced doctors and trainers in the world.

Do not miss this opportunity to learn from the inventors and developers of SCENAR technology!

SCENAR at the Landmark Classic Campdraft week in Tamworth

Great start to the Landmark Classic Campdraft week in Tamworth.

Already had numerous people through the stall, trying SCENAR for the first time with pleasing results. Even had a visit from three of our “poster pin up” testimonial clients to show their appreciation. #equinescenar.

The Equine SCENAR team for today – Heather, Vera and Anna. Stop in if you’re at the Landmark Classic!

Liv paid Anna Stevenson a visit at the SCENAR stand today and saw her poster. Drop in and see Anna at AELEC (especially if you’re feeling sore) she will make you feel better with her SCENAR therapy. Not only for horses – drop in and find out all about them.

 

A randomized study shows SCENAR is superior than TENS for pain relief

A new randomized controlled study demonstrates that SCENAR therapy is a more effective and safe method of treating patients with neck pain following whiplash compared with TENS.

DOWNLOAD the full study.

 

Abstract

 

Objective

Self-Controlled Energo-Neuro-Adaptive Regulator (SCENAR) device was introduced in 2006 as an alternative electrotherapy for pain in Korea. The aim of this study is to investigate the efficacy of SCENAR standing for SCENAR in patients with subacute neck pain following a rear-end collision.

 

Methods

A randomized and controlled prospective study was conducted on 60 patients with neck pain following rear-end collision between the ages of 20 to 50 years. Written informed consent was obtained and participants were randomly allocated to transcutaneous electrical nerve stimulation (TENS) and SCENAR therapy. The treatment regimen included 20-min treatment sessions for 4 weeks (3 times per week). Therapeutic effects were evaluated at each of the assessment points (0, 4, 8, 12 and 16 weeks) using a visual analogue scale (VAS) pain scores and neck disability index (NDI) scores.

 

Results

Eligible participants (n=70) were recruited between March 2014 and July 2015. Final trial sample (n=60) compromised 32 within the SCENAR group and 28 TENS group. The SCENAR group showed superior pain reduction compared with TENS (SCENAR: initial mean VAS score; 6.3, final mean VAS score; 2.1, TENS: initial mean VAS score; 6.2, final mean VAS score; 3.7). Sixteen week NDI scores showed the disability level of the SCENAR group (9.5) was significantly lower than that of the TENS group (14.3).

 

Conclusion

SCENAR therapy provided a significant reduction in the intensity of neck pain (VAS) and disability (NDI) compared with TENS group. SCENAR therapy is superior to the TENS therapy in reducing and disability for whiplash injury.

 

SCENAR at Landmark Classic Campdraft

 

The Equine SCENAR team will be manning a trade site at the Landmark Classic Campdraft & Sale in Tamworth from 4th-12th February.

Make sure you call in and have a free treatment for any pain in your body.

Horse demonstrations can also be organised for horses on site.

See you there!!

New Small Animals Course Launch at the Conference

We are happy the announce that SCENAR for Small Animals Course will be launched at the Conference.

Vera Payne, one of our best trainers has developed a new SCENAR course for Small Animals. Vera is going to present an extract of this course during the Conference giving some protocols to use with equine and small animals.

The Small Animals Course will initially be sold online at our training web site www.ritmscenar.com.au for the price of $200 per year and later on live seminars can be organized.

A Conference Special of 20% discount is offered to Conference Attendees. The Special price is valid till 31st of March 2017.

Equine SCENAR launch at EQUITANA!

We have had an amazing response to Equine SCENAR, treating many human clients in pain to give them a taste of what SCENAR can do for them and their horses!

Days 1 & 2 – Vera, Elly, Mel and Anna have been busy treating EQUITANA patrons to give them a taste of how SCENAR can quickly remove pain by helping the body heal itself…hoping we get a chance to treat a horse or two! If you have a horse at EQUITANA, please get one of us down to give you a demo on your horse! #equineSCENAR

RITM Australia would like to thank those SCENAR clients that gave testimonials for the EQUITANA posters. They look fantastic and have drawn many curious clients to our booth.

The Equine SCENAR Team would like to thank all the patrons and helpers we had on our stand at EQUITANA.

It was great to meet some new clients and be able to help out so many people with their pain!

We had complete strangers come and tell us of their experiences and success with SCENAR….there are some amazing stories out there!

We had an absolute blast and will be back next time!!

Please take advantage of our EQUITANA specials that will be valid until 15 December 2016!

 

  

  

 

 

      

 

RITMSCENAR aired in the Russian National TV

new-44

RITMSCENAR was featured in the National Russian TV on 2nd of November 2016.

Prof. Dr. A. Tarakanov, Head of Emergency Department in the Rostov-on-Don Hospital, Russia talked about what is SCENAR, how does it work and why this technology is so successful in providing pain relief.

The video below is in Russian language.

Our new SCENAR for Equine web site

We are pleased to advise that we just launched our new web site dedicated to Equine SCENAR Therapy.

equine_web

Early Bird discount fee ends on 30.09.2016

early_bird_1449013751601If you are planning to attend the Conference, take the advantage of the Early Bird discount fee, available until September 30th 2016.

 

Early Bird 1AU$1250 – Pay on or before 30.09.2016

Early Bird 2AU$1350 – Pay on or before 30.11.2016

Standard fees – AU$1450 – Pay on or before 13.02.2017